Steve Solberg

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Immunogenicity is a frequent cause of secondary non-response to tumour necrosis factor (TNF) inhibitors. Drug level measurement and detection of antidrug antibodies have been shown to be cost effective and clinically relevant, and a large number of assays are available for these purposes. It is, however, difficult to compare assays and translate results(More)
  • 1